ESOPJun 17, 2026, 04:16 PM
Zenas BioPharma Grants 100,000 Stock Options, 78,075 RSUs to New Hires
AI Summary
Zenas BioPharma, Inc. announced that its Compensation Committee granted 100,000 non-qualified stock options and 78,075 restricted stock units (RSUs) to newly hired employees on June 15, 2026. These inducement grants, made under Nasdaq Listing Rule 5635(c)(4), are intended to attract new talent. The stock options have a ten-year term with an exercise price of $18.71 and vest over four years, while the RSUs also vest in four equal installments over a four-year period.
Key Highlights
- Granted 100,000 non-qualified stock options to newly hired employees.
- Granted 78,075 restricted stock units (RSUs) to newly hired employees.
- Stock options have an exercise price of $18.71 per share.
- Stock options vest over a four-year period, with 25% annually.
- RSUs vest in four equal installments over a four-year period.
- Grants serve as inducement material for new employees.
Price Impact
More from ZBIO